Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Jan. 21, 2022

New TRPA1 antagonists discovered at Boehringer Ingelheim

Jan. 21, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Medshine Discovery synthesizes new JAK3 inhibitors

Jan. 20, 2022

Sun Pharmaceutical Industries divulges GIPR and GLP-1 receptor dual agonists

Jan. 20, 2022

Jiangsu Hengrui Medicine and Shanghai Hengrui Pharmaceutical patent new ATR kinase inhibitors

Jan. 20, 2022

Kallyope presents new AMPK activators

Jan. 20, 2022

New kappa-opioid receptor agonists identified at Humanwell Pharmaceutical US

Jan. 19, 2022

Charite-Universitaetsmedizin Berlin, Sapreme Technologies present new saponin derivatives

Jan. 19, 2022

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...